Micronomicin

DB13274ApprovedSmall molecule

Micronomicin is an aminoglycoside antibiotic which is marketed in Japan, and sold under the brand names Sagamicin and Luxomicina.

Mechanism: Pharmacologically active on Neuraminidase
Curator reviewed
Formula / weight: C₂₀H₄₁N₅O₇ · 463.576 g/mol (avg)

Resolves to

Compound

UNIIS9AZ0R40QVCAS52093-21-7ChEMBLCHEMBL373081ChEBI81283KEGGC17706

Clinical / RWD

RxNorm29996ATCS01AA22

Structure

InChIKeyDNYGXMICFMACRA-XHEDQWPISA-NSMILESCNC[C@@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1

Targets

P11485NA

What you can answer from here — as of July 18, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

47Drug interactionsStructured to mechanism, not free text

3Marketed productsAcross 1 country and 1 labeller

1ATC codeIncluding every combination product, plus 14 drug categories

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Micronomicin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account